Joseph S. Payne

Davis Polk advised the representatives of the initial purchasers in connection with an unregistered offering of $19 billion in aggregate principal amount of senior notes by Bristol-Myers…

Davis Polk advised the representative of the several underwriters in connection with the $81.9 million initial public offering of 6,300,000 shares of Class A common stock of Mercantil Bank…

Davis Polk advised the representatives of the underwriters in connection with the $50 million initial public offering of 6,250,000 ordinary shares of Gamida Cell Ltd. The ordinary…

Davis Polk advised Pernix Therapeutics Holdings, Inc. in connection with separate private exchange offers for its existing 12% senior secured notes due 2020 held by certain holders for new…

Davis Polk advised the initial purchasers in connection with a Rule 144A/Regulation S offering by KKR Group Finance Co. IV LLC, a wholly owned finance subsidiary of KKR & Co. L.P., of …

Davis Polk advised the joint book-running managers and as representatives of the several underwriters in connection with a public offering by PPG Industries, Inc. of $300 million aggregate…

Davis Polk advised the joint book-running managers and representatives of the several underwriters on an SEC-registered offering by Celgene Corporation of $500 million aggregate…

Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering of $400 million aggregate principal amount of 4.400% senior notes due…

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $1.74 billion secondary offering of 97,750,000 shares of Class A…

Davis Polk advised the joint book-running managers in connection with the initial public offering of 40,250,000 units of Capitol Investment Corp. IV, including 5,250,000 units…